Namibia's Directorate of Veterinary Services (DVS) has updated control measures to combat the ongoing outbreak of Lumpy Skin Disease (LSD) affecting cattle across several regions according to an ...

Biovet, a subsidiary of the Bharat Biotech Group, has received approval from the CDSCO for its innovative LSD vaccine, ...

The firm has claimed that it is the first such vaccine in the world for the highly infectious viral disease that affects ...

Bharat Biotech's group company, Biovet, has launched the world's first-ever Lumpy Skin Disease (LSD) vaccine, Biolumpivaxin, ...

Biolumpivaxin will help in disease surveillance as it means the experts will be able to distinguish between vaccinated and ...

Biolumpivaxin is a single vaccination regimen given once a year to cattle and buffaloes above 3 months of age.

In the last two years, around 200,000 cattle have died, millions lost their milk production capabilities due to LSD ...

Biovet receives CDSCO license for LSD vaccine, a game-changer for animal health, developed in collaboration with ICAR.

Bengaluru: Bharat Biotech group company Biovet, an innovative animal health vaccine producer based in Mallur, Karnataka, has ...

Biovet has secured a license from CDSCO for Biolumpivaxin, the world's only marker vaccine for Lumpy Skin Disease in cattle ...

The vaccine Biolumpivaxin, developed jointly by the Indian Council of Agricultural Research (ICAR) and Biovet, will enable ...

Bharat Biotech’s Biovet secures regulatory nod for Biolumpivaxin, developed with ICAR, to protect cattle and buffaloes from LSD ...